Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Grienke, Ulrike ^a   Richter, Martina ^b   Walther, Elisabeth ^b   Hoffmann, Anja ^b   Kirchmair, Johannes ^c   Makarov, Vadim ^d   Nietzsche, Sandor ^b   Schmidtke, Michaela ^b   Rollinger, Judith M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d BACH INSTITUTE OF BIOCHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BENZOFURAN DERIVATIVE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; FLAVANONE DERIVATIVE; FLAVONOID; SANGGENOL L; SANGGENON G; SIALIDASE; VIRAL PROTEIN;

ANTAGONISTS AND INHIBITORS; BIOFILM; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; INFLUENZA A VIRUS; MICROBIAL SENSITIVITY TEST; MORUS; PHYSIOLOGY; PLANKTON; PLANT ROOT; PRENYLATION; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL PROTEINS; BENZOFURANS; BIOFILMS; CHROMONES; ENZYME INHIBITORS; FLAVANONES; FLAVONOIDS; INFLUENZA A VIRUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MORUS; NEURAMINIDASE; PLANKTON; PLANT ROOTS; PRENYLATION; STREPTOCOCCUS PNEUMONIAE; VIRAL PROTEINS;

EID: 84973355579     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27156     Document Type: Article

References (40)

1. WHO Influenza Fact Sheets. (2015) Available at: http://www.who.int/mediacentre/factsheets/fs211/en/. (Accessed: 31st December 2015).
2. McCullers, J. A. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat. Rev. Microbiol. 12, 252-262 (2014).
3. Walther, E. et al. Dual-acting neuraminidase inhibitors open new opportunities to disrupt the lethal synergism between Streptococcus pneumoniae and influenza viruses. Front. Microbiol. 7, 357 (2016).
4. Siegel, S. J., Roche, A. M. & Weiser, J. N. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 16, 55-67 (2014).
5. Gong, J. Z., Xu, W. F. & Zhang, J. Structure and functions of influenza virus neuraminidase. Curr. Med. Chem. 14, 113-122 (2007).
6. Air, G. M. Influenza neuraminidase. Influenza Other Respir. Viruses 6, 245-256 (2012).
7. Pettigrew, M. M., Fennie, K. P., York, M. P., Daniels, J. & Ghaffar, F. Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect. Immun. 74, 3360-3365 (2006).
8. Walther, E. et al. Antipneumococcal activity of neuraminidase inhibiting artocarpin. Int. J. Med. Microbiol. 305, 289-297 (2015).
9. Mina, M. J., McCullers, J. A. & Klugman, K. P. Live attenuated influenza vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus in mice. mBio 5(1), e01040-13, doi: 10.1128/mBio.01040-13 (2014).
10. Crennell, S. J., Garman, E. F., Laver, W. G., Vimr, E. R. & Taylor, G. L. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase. Proc. Natl. Acad. Sci. USA 90, 9852-9856 (1993).
11. Roggentin, P. et al. Conserved sequences in bacterial and viral sialidases. Glycoconjugate J. 6, 349-353 (1989).
12. von Grafenstein, S. et al. Interface dynamics explain assembly dependency of influenza neuraminidase catalytic activity. J. Biomol. Struct. Dyn. 33, 104-120 (2015).
13. Richter, M. et al. Complementary assays helping to overcome challenges for identifying neuraminidase inhibitors. Future Virol. 10, 77-88 (2015).
14. Buommino, E., Scognamiglio, M., Donnarumma, G., Fiorentino, A. & D'Abrosca, B. Recent advances in natural product-based antibiofilm approaches to control infections. Mini-Rev. Med. Chem. 14, 1169-1182 (2014).
15. Kirchmair, J. et al. Novel neuraminidase inhibitors: identification, biological evaluation and investigations of the binding mode. Future Med. Chem. 3, 437-450 (2011).
16. Grienke, U. et al. Influenza neuraminidase: a druggable target for natural products. Nat. Prod. Rep. 29, 11-36 (2012).
17. Costa, S. S. et al. Flavonoids in the therapy and prophylaxis of flu: a patent review. Expert Opin. Ther. Pat. 22, 1111-1121 (2012).
18. Chamni, S. & De-Eknamkul, W. Recent progress and challenges in the discovery of new neuraminidase inhibitors. Expert Opin. Ther. Pat. 23, 409-423 (2013).
19. Kongkamnerd, J. et al. The quenching effect of flavonoids on 4-methylumbelliferone, a potential pitfall in fluorimetric neuraminidase inhibition assays. J. Biomol. Screen. 16, 755-764 (2011).
20. Grienke, U. et al. Computer-guided approach to access the anti-influenza activity of licorice constituents. J. Nat. Prod. 77, 563-570 (2014).
21. Grienke, U. et al. Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J. Med. Chem. 53, 778-786 (2010).
22. Bensky, D., Clavey, S. & Stöger, E. Chinese herbal medicine: Materia medica. 3rd edn, (Eastland Press, 2004).
23. Rollinger, J. M. et al. Venturia inaequalis-inhibiting Diels-Alder adducts from Morus root bark. J. Agr. Food Chem. 54, 8432-8436 (2006).
24. Rollinger, J. M. et al. Discovering COX-inhibiting constituents of Morus root bark: Activity-guided versus computer-aided methods. Planta Med. 71, 399-405 (2005).
25. Schade, D. et al. Zanamivir amidoxime- and N-hydroxyguanidine-based prodrug approaches to tackle poor oral bioavailability. J. Pharm. Sci. 104, 3208-3219 (2015).
26. Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739-1749 (2004).
27. King, S. J., Whatmore, A. M. & Dowson, C. G. NanA, a neuraminidase from Streptococcus pneumoniae, shows high levels of sequence diversity, at least in part through recombination with Streptococcus oralis. J. Bacteriol. 187, 5376-5386 (2005).
28. Nishikawa, T. et al. Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor. PloS one 7, e45371 (2012).
29. Chinese Pharmacopoeia Commission Pharmacopoeia of the People's Republic of China 9th edn, Chemical Industry Press, Beijing, China (2010).
30. Hano, Y., Itoh, M., Fukai, T., Nomura, T. & Urano, S. Revised structure of sanggenon B. Heterocycles 23, 1691-1696 (1985).
31. Nomura, T., Fukai, T., Hano, Y. & Uzawa, J. Structure of sanggenon C, natural hyposensitive Diels-Alder adduct from Chinese crude drug "SANG-BAI-PI" (Morus root barks). Heterocycles 16, 2141-2148 (1981).
32. Nomura, T., Fukai, T., Hano, Y. & Uzawa, J. Structure of sanggenon D, a natural hyposensitive Diels-Alder adduct from Chinese crude drug "SANG-BAI-PI" (Morus root barks). Heterocycles 17, 381-389 (1982).
33. Fukai, T., Hano, Y., Fujimoto, T. & Nomura, T. Structure of sanggenon G, a new Diels-Alder adduct from the Chinese crude drug "SANG-BAI-PI" (Morus root barks). Heterocycles 20, 611-615 (1983).
34. Fukai, T. et al. Isoprenylated flavanones from Morus cathayana. Phytochemistry 47, 273-280 (1998).
35. Hano, Y., Suzuki, S., Kohno, H. & Nomura, T. Absolute configuration of kuwanon L, a Diels-Alder type adduct from the Morus root bark. Heterocycles 27, 75-82 (1988).
36. Hano, Y., Suzuki, S., Nomura, T. & Iitaka, Y. Absolute configuration of natural Diels-Alder type adducts from the Morus root bark. Heterocycles 27, 2315-2326 (1988).
37. Kaur, N. et al. The first total synthesis of moracin O and moracin P, and establishment of the absolute configuration of moracin O. Chem. Commun. 1879-1881, doi: 10.1039/B823340C (2009).
38. Schade, D. et al. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A. J. Med. Chem. 57, 759-769 (2014).
39. Okomo-Adhiambo, M. et al. Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) viruses. Antivir. Res. 85, 381-388 (2010).
40. Schmidtke, M., Schnittler, U., Jahn, B., Dahse, H. & Stelzner, A. A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. J. Virol. Methods 95, 133-143 (2001).